Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision Glucocorticoid Intervention in CAP-ARF
NCT07357935Phase 2Not yet recruiting
- Sponsor
- Qingyuan Zhan
- Start
- Feb 2026
- Primary completion
- Sep 2028
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of methylprednisolone in acute respiratory failure (ARF), community acquired pneumonia (CAP), sponsored by Qingyuan Zhan. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
acute respiratory failure (ARF)community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT07357935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07357935.